Bénéfices
| Q1 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | -0.290 | ||
| Révision: | $973.85M | $1.04B | — |
| Q4 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | -0.390 | -0.59 | |
| Révision: | $926.13M | $999.40M | $50.37M |
| Q3 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 0.260 | 1.260 | 1.0000 |
| Révision: | $1.04B | $1.17B | $109.00M |
| Q2 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | -0.070 | -0.230 | -0.1600 |
| Révision: | $1.09B | $1.42B | -$72.00M |
